Anti-tumor effects and mechanism of GA-13315, a novel gibberellin derivative, in human lung adenocarcinoma: an in vitro and in vivo study

[1]  T. Ohnishi,et al.  Detection of epidermal growth factor receptor mutations in lung adenocarcinoma cytological specimens by immunocytochemistry , 2017, Molecular and clinical oncology.

[2]  S. Shen,et al.  Effects and mechanism of GA-13315 on the proliferation and apoptosis of KB cells in oral cancer , 2017, Oncology letters.

[3]  Min H. Kang,et al.  Gibberellin derivative GA-13315 sensitizes multidrug-resistant cancer cells by antagonizing ABCB1 while agonizes ABCC1 , 2016, Cancer Chemotherapy and Pharmacology.

[4]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[5]  D. Jiang,et al.  Polydatin promotes apoptosis through upregulation the ratio of Bax/Bcl-2 and inhibits proliferation by attenuating the β-catenin signaling in human osteosarcoma cells. , 2016, American journal of translational research.

[6]  Simin Sharifi,et al.  Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells. , 2015, Advanced pharmaceutical bulletin.

[7]  A. Farazmand,et al.  MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis , 2015, Autoimmunity.

[8]  M. Gail,et al.  Lung cancer prognosis before and after recurrence in a population-based setting. , 2015, Journal of the National Cancer Institute.

[9]  Yilin Yang,et al.  Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway , 2015, OncoTargets and therapy.

[10]  Jinbao Liu,et al.  Anacardic acid induces cell apoptosis associated with induction of ATF4-dependent endoplasmic reticulum stress. , 2014, Toxicology letters.

[11]  M. Ginsberg,et al.  Epidemiology of Lung Cancer , 2013, Seminars in Interventional Radiology.

[12]  H. Hricak,et al.  Advances in oncologic imaging , 2012, CA: a cancer journal for clinicians.

[13]  G. Goss,et al.  Drug resistance and its significance for treatment decisions in non-small-cell lung cancer. , 2012, Current oncology.

[14]  Xianghui Zeng,et al.  Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative , 2012, Investigational New Drugs.

[15]  Yong-feng Yu,et al.  Maintenance therapy for NSCLC: Consensus and controversy , 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[16]  B. Tudzynski,et al.  Diversity, regulation, and evolution of the gibberellin biosynthetic pathway in fungi compared to plants and bacteria. , 2009, Phytochemistry.

[17]  Hongbin Zhang,et al.  Synthesis of gibberellin derivatives with anti-tumor bioactivities. , 2009, Bioorganic & medicinal chemistry letters.

[18]  N. Thatcher,et al.  First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view , 2008, BMC proceedings.

[19]  Afshin Samali,et al.  Mediators of endoplasmic reticulum stress‐induced apoptosis , 2006, EMBO reports.

[20]  Christopher T. Walsh,et al.  Lessons from natural molecules , 2004, Nature.

[21]  Johan Hansson,et al.  Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic Signaling* , 2003, The Journal of Biological Chemistry.

[22]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.